A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
Not yet recruiting · NCT07677514 · Registry updated 2026-06-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Not yet recruiting | Phase 2 | 2026-06-30 | NCT07677514 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu Carephar Pharmaceutical Co., Ltd. | 1 |
24 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.